274 related articles for article (PubMed ID: 18823890)
1. The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease.
Pawlak K; Domaniewski T; Mysliwiec M; Pawlak D
Atherosclerosis; 2009 May; 204(1):309-14. PubMed ID: 18823890
[TBL] [Abstract][Full Text] [Related]
2. Kynurenine, quinolinic acid--the new factors linked to carotid atherosclerosis in patients with end-stage renal disease.
Pawlak K; Brzosko S; Mysliwiec M; Pawlak D
Atherosclerosis; 2009 Jun; 204(2):561-6. PubMed ID: 19027117
[TBL] [Abstract][Full Text] [Related]
3. Kynurenines and oxidative status are independently associated with thrombomodulin and von Willebrand factor levels in patients with end-stage renal disease.
Pawlak K; Domaniewski T; Mysliwiec M; Pawlak D
Thromb Res; 2009 Sep; 124(4):452-7. PubMed ID: 19477487
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor/its pathway inhibitor system and kynurenines in chronic kidney disease patients on conservative treatment.
Pawlak K; Tankiewicz J; Mysliwiec M; Pawlak D
Blood Coagul Fibrinolysis; 2009 Oct; 20(7):590-4. PubMed ID: 19491664
[TBL] [Abstract][Full Text] [Related]
5. Hyperfibrinolysis, uPA/suPAR system, kynurenines, and the prevalence of cardiovascular disease in patients with chronic renal failure on conservative treatment.
Pawlak K; Buraczewska-Buczko A; Mysliwiec M; Pawlak D
Am J Med Sci; 2010 Jan; 339(1):5-9. PubMed ID: 19926968
[TBL] [Abstract][Full Text] [Related]
6. Inflammation but not oxidative stress is associated with beta-chemokine levels and prevalence of cardiovascular disease in uraemic patients.
Pawlak K; Pawlak D; Myśliwiec M
Cytokine; 2006 Sep; 35(5-6):258-62. PubMed ID: 17070067
[TBL] [Abstract][Full Text] [Related]
7. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
[TBL] [Abstract][Full Text] [Related]
8. Cu/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease.
Pawlak K; Pawlak D; Mysliwiec M
Clin Biochem; 2005 Aug; 38(8):700-5. PubMed ID: 15963971
[TBL] [Abstract][Full Text] [Related]
9. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
10. Kynurenine and its metabolites--kynurenic acid and anthranilic acid are associated with soluble endothelial adhesion molecules and oxidative status in patients with chronic kidney disease.
Pawlak K; Kowalewska A; Mysliwiec M; Pawlak D
Am J Med Sci; 2009 Oct; 338(4):293-300. PubMed ID: 19745702
[TBL] [Abstract][Full Text] [Related]
11. Impact of cholesterol lowering treatment on plasma kynurenine and tryptophan concentrations in chronic kidney disease: relationship with oxidative stress improvement.
Zinellu A; Sotgia S; Mangoni AA; Sanna M; Satta AE; Carru C
Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):153-9. PubMed ID: 25534866
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2007; 120(6):871-6. PubMed ID: 17331567
[TBL] [Abstract][Full Text] [Related]
13. Hypercoagulability is independently associated with kynurenine pathway activation in dialysed uraemic patients.
Pawlak K; Mysliwiec M; Pawlak D
Thromb Haemost; 2009 Jul; 102(1):49-55. PubMed ID: 19572067
[TBL] [Abstract][Full Text] [Related]
14. Kynurenine pathway - a new link between endothelial dysfunction and carotid atherosclerosis in chronic kidney disease patients.
Pawlak K; Myśliwiec M; Pawlak D
Adv Med Sci; 2010; 55(2):196-203. PubMed ID: 20439183
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress influences CC-chemokine levels in hemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Nephron Physiol; 2004; 96(4):p105-12. PubMed ID: 15122056
[TBL] [Abstract][Full Text] [Related]
16. Increased pretransplantation plasma kynurenine levels do not protect from but predict acute kidney allograft rejection.
Lahdou I; Sadeghi M; Daniel V; Schenk M; Renner F; Weimer R; Löb S; Schmidt J; Mehrabi A; Schnitzler P; Königsrainer A; Döhler B; Opelz G; Terness P
Hum Immunol; 2010 Nov; 71(11):1067-72. PubMed ID: 20732369
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress, phosphate and creatinine levels are independently associated with vascular endothelial growth factor levels in patients with chronic renal failure.
Pawlak K; Mysliwiec M; Pawlak D
Cytokine; 2008 Jul; 43(1):98-101. PubMed ID: 18455421
[TBL] [Abstract][Full Text] [Related]
18. Increased kynurenine plasma concentrations and kynurenine-tryptophan ratio in mild-to-moderate chronic obstructive pulmonary disease patients.
Zinellu A; Fois AG; Zinellu E; Sotgiu E; Sotgia S; Arru D; Mangoni AA; Carru C; Pirina P
Biomark Med; 2018 Mar; 12(3):229-237. PubMed ID: 29506391
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin and cardiovascular remodeling in end-stage renal disease and co-morbid diabetes mellitus.
Karakitsos D; De Groot E; Patrianakos AP; Parthenakis F; Boletis J; Karabinis A; Kyriazis J; Vardas P; Daphnis E
Am J Nephrol; 2006; 26(4):340-7. PubMed ID: 16825760
[TBL] [Abstract][Full Text] [Related]
20. Haemostatic system, biochemical profiles, kynurenines and the prevalence of cardiovascular disease in peritoneally dialyzed patients.
Pawlak K; Mysliwiec M; Pawlak D
Thromb Res; 2010 Feb; 125(2):e40-5. PubMed ID: 19732942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
